| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $307.0M | +41.0% |
| SG&A Expense | $107.3M | +71.5% |
| Operating Income | -$414.3M | -47.8% |
| Pre-tax Income | -$424.8M | -63.4% |
| Income Tax | $585K | -23.4% |
| Net Income | -$425.4M | -63.1% |
| EPS (Basic) | -$5.85 | -48.9% |
| EPS (Diluted) | -$5.85 | -48.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $261.7M | +79.7% |
| Short-term Investments | $1.11B | +14.1% |
| Current Assets | $1.39B | +23.0% |
| Total Assets | $1.41B | +23.7% |
| Current Liabilities | $91.2M | +68.8% |
| Total Liabilities | $164.4M | +128.4% |
| Stockholders' Equity | $1.25B | +16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$275.2M | -48.7% |
| Investing Cash Flow | -$124.1M | +78.4% |
| Financing Cash Flow | $515.3M | -9.4% |